- Home
- FMBH vs NEO Comparison
FMBH vs NEO Comparison
Compare FMBH & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMBH
- NEO
- Stock Information
- Founded
- FMBH 1865
- NEO 2001
- Country
- FMBH United States
- NEO United States
- Employees
- FMBH N/A
- NEO N/A
- Industry
- FMBH Major Banks
- NEO Precision Instruments
- Sector
- FMBH Finance
- NEO Health Care
- Exchange
- FMBH Nasdaq
- NEO Nasdaq
- Market Cap
- FMBH 974.1M
- NEO 1.1B
- IPO Year
- FMBH N/A
- NEO 1999
- Fundamental
- Price
- FMBH $36.30
- NEO $9.00
- Analyst Decision
- FMBH Hold
- NEO Buy
- Analyst Count
- FMBH 5
- NEO 10
- Target Price
- FMBH $43.40
- NEO $12.56
- AVG Volume (30 Days)
- FMBH 61.0K
- NEO 3.0M
- Earning Date
- FMBH 10-30-2025
- NEO 10-28-2025
- Dividend Yield
- FMBH 2.76%
- NEO N/A
- EPS Growth
- FMBH 13.11
- NEO N/A
- EPS
- FMBH 3.52
- NEO N/A
- Revenue
- FMBH $328,480,000.00
- NEO $689,189,000.00
- Revenue This Year
- FMBH N/A
- NEO $10.40
- Revenue Next Year
- FMBH $4.20
- NEO $10.11
- P/E Ratio
- FMBH $10.29
- NEO N/A
- Revenue Growth
- FMBH 7.81
- NEO 9.70
- 52 Week Low
- FMBH $27.58
- NEO $4.72
- 52 Week High
- FMBH $43.86
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- FMBH 30.69
- NEO 64.32
- Support Level
- FMBH $36.47
- NEO $7.56
- Resistance Level
- FMBH $38.01
- NEO $9.47
- Average True Range (ATR)
- FMBH 0.85
- NEO 0.38
- MACD
- FMBH -0.25
- NEO 0.05
- Stochastic Oscillator
- FMBH 5.54
- NEO 76.64
About FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.